CytomX Therapeutics Cash Flow Statement (2014-2026) | CTMX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M	-22.67M	-18.25M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	3.42M	1.84M	3.54M	3.37M	2.09M	2.30M	-10.50M	2.41M	1.70M	1.23M	2.55M	1.91M	1.50M	1.30M	1.88M	2.01M	0.20M	0.80M	1.48M	4.71M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)	-28.20M	-29.70M	-31.19M	-41.31M	-34.24M	-33.84M	-1.39M	9.35M	-25.18M	-18.24M	-21.96M	-26.05M	-19.55M	-20.73M	-19.91M	-21.04M	-15.75M	-15.55M	-23.24M	-25.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.14M	-0.01M	0.01M	0.02M	0.02M	0.01M	0.01M	1.53M	1.73M	1.93M	2.23M	1.87M	1.44M	1.22M	0.79M	0.45M	0.40M	0.64M	0.72M	0.73M
Depreciation & Amortization (CF) (Quarter)	0.64M	0.64M	0.64M	0.56M	0.57M	0.59M	0.57M	0.56M	0.57M	0.45M	0.45M	0.43M	0.42M	0.39M	0.38M	0.35M	0.31M	0.10M	0.47M	0.21M
Change in Working Capital
Change in Receivables (Quarter)	0.17M	-0.04M	-0.10M	0.23M	0.06M	0.70M	34.21M	-34.90M	0.81M	0.52M	1.01M	9.74M	-10.40M	0.58M	-0.25M	-1.15M	-0.09M	-0.24M	0.38M	-1.37M
Change in Account Payables (Quarter)	-0.88M	-0.18M	1.22M	-1.06M	0.22M	3.29M	-2.37M	-0.62M	-1.16M	0.68M	-0.33M	0.58M	-1.43M	0.81M	-0.26M	-0.80M	-0.05M	0.42M	0.66M	0.07M
Change in Accured Expenses (Quarter)	-0.46M	5.01M	8.11M	-4.18M	-0.30M	-1.41M	-3.89M	-7.36M	-3.12M	2.01M	1.42M	-4.43M	-1.67M	2.03M	-5.55M	-2.11M	-1.10M	-0.33M	0.49M	-3.60M
Other Working Capital Changes (Quarter)	-1.34M	0.00M	-0.00M	0.61M	-0.62M	-0.00M	3.19M	-0.78M	-1.58M	-0.37M	0.32M	-1.21M	-0.67M	0.11M	0.34M	1.20M	-0.13M	-0.71M	0.87M	0.89M
Investing Activities
Capital Expenditures (Quarter)	0.11M	0.27M	0.24M	0.74M	0.41M	0.41M	0.18M	0.05M	0.52M	0.01M	-0.50M	0.12M	0.10M	0.02M	0.08M	0.12M	0.03M	-0.13M	0.20M
Change in Acquisitions & Divestments (Quarter)	54.00M	10.00M					100.00M		100.00M	50.00M	125.00M	45.00M	115.00M	30.50M	65.00M	50.50M	32.50M	20.00M	30.00M	50.00M
Cash from Investing Activities (Quarter)	-46.01M	9.73M	-0.24M	-0.74M	-0.41M	-0.41M	99.82M	-146.64M	26.04M	-42.94M	12.87M	44.88M	21.51M	18.17M	15.13M	30.60M	-76.36M	0.44M	-14.42M	-192.78M
Financing Activities
Other financing activities (Quarter)	0.69M	0.10M	0.68M	0.01M	0.45M	-0.46M			0.32M	29.35M		0.17M	0.26M		-0.43M		0.18M	0.25M	0.38M	5.86M
Cash from Financing Activities (Quarter)	0.69M	0.10M	0.68M	0.01M	0.45M		0.19M		0.32M	29.67M	0.24M	0.17M	5.10M		2.25M		93.55M	0.25M	16.64M	234.49M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)													0.04M		2.07M		93.37M		16.30M	228.35M
Additional items
Change in Cash (Quarter)	-73.52M	-19.86M	-30.75M	-42.04M	-34.20M	-34.26M	98.61M	-137.29M	1.18M	-31.51M	-8.85M	19.01M	7.06M	-2.56M	-2.52M	9.55M	1.44M	-14.86M	-21.02M	16.16M
Free Cash Flow (Quarter)	-28.31M	-29.97M	-31.44M	-42.05M	-34.65M	-34.26M	-1.57M	9.30M	-25.70M	-18.25M	-21.46M	-26.16M	-19.64M	-20.75M	-19.99M	-21.16M	-15.78M	-15.42M	-23.44M	-25.55M
Net Cash Flow (Quarter)	-73.52M	-19.86M	-30.75M	-42.04M	-34.20M	-34.26M	98.61M	-137.29M	1.18M	-31.51M	-8.85M	19.01M	7.06M	-2.56M	-2.52M	9.55M	1.44M	-14.86M	-21.02M	16.16M

Research Tools

Developers

CytomX Therapeutics Cash Flow Statement (2014-2026) | CTMX

Research Tools

Developers

CytomX Therapeutics Cash Flow Statement (2014-2026) | CTMX

Create an account

Sign In

Reset Password